Endocrine-based strategies after CDK4/6 inhibitors in biomarker-selected subgroup of hormone receptor positive advanced breast cancer: A systematic review and network meta-analysis
Year: 2025
Type: review
Language: en
Topic: Advanced Breast Cancer Therapies
Authors and affiliations:
raw_author_name: Alicia Escudero
raw_affiliation_strings: Health Research Institute, Hospital Clínico San Carlos (IdISSC), Department of Oncology, Madrid, Spain
raw_author_name: Meritxell Bellet
raw_affiliation_strings: SOLTI Cancer Research Group, Barcelona, Spain; Medical Oncology Department, Vall d'Hebron University Hospital, and Breast Cancer Group, D'Hebron Institute of Oncology (VHIO), Barcelona, Spain
raw_author_name: Cristina Saura
raw_affiliation_strings: SOLTI Cancer Research Group, Barcelona, Spain; Medical Oncology Department, Vall d'Hebron University Hospital, and Breast Cancer Group, D'Hebron Institute of Oncology (VHIO), Barcelona, Spain
raw_author_name: Anna Aguilera
raw_affiliation_strings: Statistics Unit, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain
raw_author_name: Andri Papakonstantinou
raw_affiliation_strings: Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden; Department of Breast Cancer, Endocrine Tumours and Sarcoma, Karolinska Comprehensive Cancer Center and Karolinska University Hospital, Stockholm, Sweden
raw_author_name: Pablo Tolosa
raw_affiliation_strings: SOLTI Cancer Research Group, Barcelona, Spain; Research Institute Hospital 12 de Octubre (i+12), Madrid, Spain; Hospital Universitario 12 de Octubre, Madrid, Spain
raw_author_name: José Ángel García-Sáenz
raw_affiliation_strings: Health Research Institute, Hospital Clínico San Carlos (IdISSC), Department of Oncology, Madrid, Spain; GEICAM, Spanish Breast Cancer Group, Madrid, Spain
raw_author_name: Fernando Moreno
raw_affiliation_strings: Health Research Institute, Hospital Clínico San Carlos (IdISSC), Department of Oncology, Madrid, Spain; GEICAM, Spanish Breast Cancer Group, Madrid, Spain
raw_author_name: Alfonso López de Sá
raw_affiliation_strings: Health Research Institute, Hospital Clínico San Carlos (IdISSC), Department of Oncology, Madrid, Spain; GEICAM, Spanish Breast Cancer Group, Madrid, Spain
raw_author_name: Francesco Schettini
raw_affiliation_strings: SOLTI Cancer Research Group, Barcelona, Spain; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Clinic Barcelona Comprehensive Cancer Center, Hospital Clinic of Barcelona, Barcelona, Spain
raw_author_name: Elia Seguí
raw_affiliation_strings: SOLTI Cancer Research Group, Barcelona, Spain; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Clinic Barcelona Comprehensive Cancer Center, Hospital Clinic of Barcelona, Barcelona, Spain; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA; Harvard Medical School, Boston, MA, USA
raw_author_name: Marta Gonzalez-Rodriguez
raw_affiliation_strings: Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Clinic Barcelona Comprehensive Cancer Center, Hospital Clinic of Barcelona, Barcelona, Spain
raw_author_name: Victor Navarro
raw_affiliation_strings: Statistics Unit, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain
raw_author_name: Juan Manuel Ferrero-Cafiero
raw_affiliation_strings: SOLTI Cancer Research Group, Barcelona, Spain
raw_author_name: Xavier González
raw_affiliation_strings: SOLTI Cancer Research Group, Barcelona, Spain; Institut Oncològic Dr. Rosell, Barcelona, Spain; Hospital General de Catalunya, Sant Cugat del Vallès, Spain; Universitat Internacional de Catalunya, Sant Cugat del Vallès, Spain
raw_author_name: Cristina Hernando
raw_affiliation_strings: Valencian Institute of Oncology (IVO), Department of Oncology, Valencia, Spain
raw_author_name: Alexios Matikas
raw_affiliation_strings: Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden; Department of Breast Cancer, Endocrine Tumours and Sarcoma, Karolinska Comprehensive Cancer Center and Karolinska University Hospital, Stockholm, Sweden
raw_author_name: Aleix Prat
raw_affiliation_strings: Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Clinic Barcelona Comprehensive Cancer Center, Hospital Clinic of Barcelona, Barcelona, Spain; Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain; Reveal Genomics, Barcelona, Spain; Institute of Oncology (IOB)-Quirón, Barcelona, Spain
raw_author_name: Mafalda Oliveira
raw_affiliation_strings: SOLTI Cancer Research Group, Barcelona, Spain; Medical Oncology Department, Vall d'Hebron University Hospital, and Breast Cancer Group, D'Hebron Institute of Oncology (VHIO), Barcelona, Spain
raw_author_name: Tomas Pascual
raw_affiliation_strings: SOLTI Cancer Research Group, Barcelona, Spain; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Clinic Barcelona Comprehensive Cancer Center, Hospital Clinic of Barcelona, Barcelona, Spain; Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain
raw_author_name: Guillermo Villacampa
raw_affiliation_strings: SOLTI Cancer Research Group, Barcelona, Spain; Statistics Unit, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain; Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain. Electronic address: guillermo.villacampa@gruposolti.org